Cme (CME) Revenue (2009 - 2026)

Cme (CME) has reported Revenue for 18 consecutive years, with $1.7 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Revenue rose 0.84% year-over-year to $1.7 billion in Q2 2026; TTM through Jun 2026 was $6.8 billion, a 5.1% increase from a year earlier, with the FY2025 full-year figure at $6.5 billion, up 6.37% from the prior year.
• Revenue was $1.7 billion for Q2 2026 at Cme, down from $1.9 billion in the prior quarter.
• Over five years, Revenue peaked at $1.9 billion in Q1 2026 and troughed at $1.2 billion in Q4 2022.
• A 5-year average of $1.5 billion and a median of $1.5 billion in 2024 frame the typical range for Revenue.
• Across the five-year window, Revenue rose 19.17% in 2023 and fell 2.95% in 2025, its largest moves.
• Over 5 years, Revenue stood at $1.2 billion in 2022, then climbed by 19.17% to $1.4 billion in 2023, then grew by 5.98% to $1.5 billion in 2024, then rose by 8.09% to $1.6 billion in 2025, then increased by 3.49% to $1.7 billion in 2026.
• The last three Revenue figures came in at $1.7 billion (Q2 2026), $1.9 billion (Q1 2026), and $1.6 billion (Q4 2025), per Business Quant data.